[1P-0517] Application of CRISPR-Cas13 machinery in disease treatment

〇Mr. Saifullah¹、Matomo Sakari ¹、Toshifumi Tsukahara^1,2 (1.Area of Bioscience and Biotechnology, School of Materials Science, Japan Advanced Institute of Science and Technology (JAIST)、2.Division of Transdisciplinary Science, Japan Advanced Institute of Science and Technology (JAIST))

CRISPR-Cas13a、RNA breakdown、Luciferase breakdown、EML4-ALK fusion、NSCLCs